FindTrial
Sign In

Acute opioid tolerance as revealed by functional magnetic resonance imaging.

Acute opioid tolerance as revealed by functional magnetic resonance imaging.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-004250-81-FI
Enrollment
Unknown
Registered
2007-08-17
Start date
2007-09-11
Completion date
Unknown
Last updated
2013-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

akuutti opioiditoleranssi MedDRA version: 9.1 Level: LLT Classification code 10052804 Term: Drug tolerance

Interventions

Trade Name: Ultiva Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN: REMIFENTANIL CAS Number: 132875617 Pharmaceutical form of the placebo: Injection* Route of administr

Sponsors

Helsinki University Central Hospital, Pain Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026